News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,278 Results
Type
Article (14287)
Company Profile (281)
Press Release (254710)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79547)
Career Advice (153)
Deals (13236)
Drug Delivery (35)
Drug Development (50471)
Employer Resources (31)
FDA (5730)
Job Trends (5140)
News (144469)
Policy (10034)
Tag
Academia (916)
Accelerated approval (3)
Adcomms (13)
Allergies (52)
Alliances (21688)
ALS (69)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (110)
Approvals (5756)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (164)
Cancer (1545)
Cardiovascular disease (122)
Career advice (134)
Career pathing (2)
CAR-T (127)
Cell therapy (349)
Cervical cancer (9)
Clinical research (41203)
Collaboration (569)
Compensation (284)
Complete response letters (13)
COVID-19 (1034)
CRISPR (46)
C-suite (173)
Cystic fibrosis (78)
Data (1649)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (95)
Earnings (30280)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48869)
Executive appointments (478)
FDA (6516)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (524)
Gene editing (104)
Generative AI (10)
Gene therapy (274)
GLP-1 (375)
Government (1084)
Grass and pollen (2)
Guidances (75)
Healthcare (6596)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7283)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1388)
Liver cancer (34)
Lung cancer (212)
Lymphoma (107)
Machine learning (5)
Management (7)
Manufacturing (149)
MASH (65)
Medical device (2604)
Medtech (2605)
Mergers & acquisitions (6295)
Metabolic disorders (416)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (77)
Neuropsychiatric disorders (26)
Neuroscience (1289)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (23)
Obesity (201)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (126)
Partnered (8)
Patents (141)
Patient recruitment (84)
Peanut (35)
People (25694)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14563)
Phase II (19174)
Phase III (12101)
Pipeline (1000)
Policy (49)
Postmarket research (852)
Preclinical (6172)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (302)
Real estate (1419)
Recruiting (12)
Regulatory (8682)
Reports (18)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (7)
RSV (10)
Schizophrenia (64)
Series A (103)
Series B (70)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (218)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (166)
Last 7 days (643)
Last 30 days (2117)
Last 365 days (19357)
2025 (7455)
2024 (20553)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17363)
Australia (2948)
California (4185)
Canada (1196)
China (379)
Colorado (159)
Connecticut (157)
Delaware (111)
Europe (37388)
Florida (510)
Georgia (128)
Idaho (16)
Illinois (245)
India (10)
Indiana (94)
Iowa (3)
Japan (83)
Kansas (64)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (502)
Massachusetts (3318)
Michigan (77)
Minnesota (155)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1022)
New Mexico (12)
New York (1110)
North Carolina (579)
North Dakota (6)
Northern California (1870)
Ohio (118)
Oklahoma (9)
Oregon (21)
Pennsylvania (782)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1599)
Tennessee (26)
Texas (484)
United States (14219)
Utah (56)
Virginia (87)
Washington D.C. (32)
Washington State (370)
Wisconsin (19)
269,278 Results for "kyverna therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
May 14, 2025
·
11 min read
Press Releases
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
March 3, 2025
·
1 min read
Press Releases
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 28, 2025
·
11 min read
Layoff Tracker
Kyverna Cut Off 16% of Staff in Q1
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 15, 2025
·
205 min read
·
BioSpace Editorial Staff
Press Releases
Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
January 21, 2025
·
7 min read
Press Releases
Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
January 7, 2025
·
3 min read
Press Releases
Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth
December 16, 2024
·
6 min read
Biotech Bay
Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024
Kyverna Therapeutics, Inc. announced today that it will host a sponsored symposium to present the largest and most diverse set of data to date from a cohort of 50 patients treated with the CAR in KYV-101, an autologous, fully human anti-CD19 CAR T-cell immunotherapy.
June 7, 2024
·
5 min read
Press Releases
Kyverna Therapeutics Announces Leadership Update
September 16, 2024
·
8 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
1 of 26,928
Next
